Covidien (COV) Expands Global Research and Development Presence
3/8/2012 6:44:48 AM
MANSFIELD, Mass.--(BUSINESS WIRE)--Covidien (NYSE:COV), a leading global provider of healthcare products, today announced the opening of four research and development (R&D) centers. The R&D facilities are located in: Boulder, Colorado; Hyderabad, India; Irvine, California; and Trevoux, France.
comments powered by